Delcath Systems

DCTH-Q

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about DCTH-Q

Signal
Opinion
Expert
COMMENT
COMMENT
February 11, 2011
Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
Show full opinionHide full opinion
Delcath Systems (DCTH-Q)
February 11, 2011
Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
TOP PICK
TOP PICK
July 22, 2010
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Show full opinionHide full opinion
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »